Sexual chemistry: Pfizer & the search for the new Viagra
Drug companies spend billions of pounds chasing “the next big thing” – the wonder pill that will change the world and earn millions for its creators. Viagra, discovered by chance by pharmacists seeking a treatment for angina, is just such a drug.
Drug companies spend billions of pounds chasing “the next big thing” – the wonder pill that will change the world and earn millions for its creators. Viagra, discovered by chance by pharmacists seeking a treatment for angina, is just such a drug.
Pfizer, the US colossus that holds the patent, earned $1.6bn (£800m; E1.2bn) from Viagra sales last year. This is big money, even in an industry known for its blockbuster earnings.
But standing still is a recipe for disaster and Pfizer risks squandering Viagra's legacy. With fake Viagra flooding the internet and British rival, GlaxoSmithKline (GSK), working on a gel that could be widely available in chemists by 2009 (unlike Pfizer's little blue pill, which requires a doctor's prescription), Pfizer is playing a desperate game of catch up.
As The Business revealed last week, the company is discussing an over-the-counter version of Viagra aimed at boosting sales and seeing-off challenges from rivals such as GSK.
More articles from: | this section
Post this entry to: del.icio.us | Digg | Newsvine | NowPublic | Reddit
Advertisement
How the Tories can still win in Europe
Fraser NelsonSleepwalking into disaster in Afghanistan
John C. Hulsman
Pavel Stroilov
Listen up, Dave: to care is not to do
David FrumPopular Blogger Posts
sponsored links
GASCONY
GASCONY, SW France, near Condom-en-Armagnac 13th Century stone house, 21st Century luxury for 12 in 5 en-suites. 50 acres +
BIG SAND STEEL BAND
IF YOU ARE PLANNING A CHAMPAGNE RECEPTION and looking for some light entertainment, you can now hire London's busiest steel
BOSC LEBAT, Tarn et Garonne.
BOSC LEBAT, SW France. Only 45 minutes from Toulouse Airport with daily flights from most provincial airports avoiding the horrors
Spectator Business | Apollo Magazine
Corporate | Advertising | Privacy | Terms
Spectator, 22 Old Queen Street, London, SW1H 9HP
All Articles and Content Copyright ©2009 by The Spectator | All Rights Reserved
paul witten
January 19th, 2007 5:34pm Report this commentyou should have mentioned in the article that Glaxo's junior partner who brought the drug to Glaxo is a little known company called Futura.
Back to top